About the Company
We do not have any company description for ARTELO BIOSCIENCES, INC. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ARTL News
Artelo Biosciences Inc ARTL
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
SOLANA BEACH, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop ...
Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge
SOLANA BEACH, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to ...
Artelo Biosciences, Inc. (ARTL)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain ...
Artelo Biosciences Inc. Wt
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Artelo Biosciences Inc ARTL
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Artelo Biosciences Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Artelo Biosciences Inc (ARTL)
Investing.com – U.S. stocks were mixed after the close on Friday, as gains in the Oil & Gas, Industrials and Healthcare sectors led shares higher while losses in the Utilities, ...
Artelo Biosciences Inc (ARTL)
SOLANA BEACH, Calif. - Artelo Biosciences , Inc. (NASDAQ:ARTL), a clinical-stage biopharmaceutical company, has been selected as a finalist in the Johnson & Johnson... Artelo Biosciences, Inc., a ...
Loading the latest forecasts...